Europe Anti-snoring Device Market Size and Forecast 2025–2033

According to Renub Research Europe Anti-snoring Device Market is projected to increase from US$ 485.18 million in 2024 to US$ 919.37 million by 2033, registering a CAGR of 7.36% throughout 2025–2033. This expansion is driven by a rising awareness of the health consequences of snoring, growth in Europe’s elderly and obese populations, lifestyle changes such as higher alcohol and tobacco consumption, and a sizable undiagnosed population suffering from sleep-related disorders.

The market includes a diverse range of non-invasive products designed to reduce snoring and mild to moderate sleep apnea, including oral appliances, nasal dilators, tongue-stabilizing devices, positional therapy tools, chin straps, and EPAP devices. Consumer demand is increasing due to the desire for accessible, home-based solutions that improve sleep quality without the need for surgical intervention.

Request a free sample copy of the report:https://www.renub.com/request-sample-page.php?gturl=europe-anti-snoring-device-market-p.php

Europe Anti-snoring Device Market Overview

The European anti-snoring device market continues to grow due to the increasing prevalence of obstructive sleep apnea (OSA), rising awareness of sleep health, and expanding access to non-invasive treatment options. Snoring is widespread across Europe, particularly among older adults and individuals with obesity, making it a significant public health concern. As healthcare systems prioritize early screening and diagnosis of sleep disorders, demand for assistive devices continues to rise.

Technological innovation is reshaping the industry. Many modern anti-snoring devices now incorporate smart features such as vibration alerts, sleep monitoring, and mobile app integration. Custom-fit oral appliances and adjustable devices designed for enhanced comfort are becoming more common, appealing to patients seeking alternatives to CPAP therapy. The strong growth of e-commerce and telemedicine across Europe has improved access to both prescription-based and OTC products, enabling consumers to research, consult, and purchase solutions remotely.

Despite favorable market growth, several challenges persist. Lack of public awareness in certain regions, poor patient adherence due to device discomfort, and varying regulatory requirements across Europe complicate adoption. However, as sleep clinics expand, awareness campaigns increase, and device designs improve, the market is positioned for sustained, long-term growth.

Key Factors Driving Market Growth in Europe

Aging Population and Lifestyle Trends
Europe’s demographic shift toward an older population significantly increases the prevalence of snoring and OSA. Age-related muscle relaxation, excess fatty tissue around the neck, and comorbid chronic conditions contribute to airway obstruction during sleep. At the same time, lifestyle-related factors such as obesity, alcohol intake, and sedentary routines are rising among younger populations, further increasing the incidence of snoring. As awareness grows, many adults prefer non-invasive anti-snoring solutions to improve sleep quality and overall well-being.

Technological Advancements and Innovative Product Design
Continuous product innovation is a major driver of market growth. Manufacturers are incorporating advanced technologies—such as vibration sensors, AI-driven sleep tracking, mobile app integration, and custom-molded device designs—to create solutions that are both effective and comfortable. These innovations help improve adherence and enable personalized sleep management. Modern mandibular advancement devices, positional therapy wearables, and smart nasal dilators are gaining traction among patients seeking alternatives to CPAP.

Increasing Awareness and Sleep Health Education
Awareness campaigns by health organizations, sleep clinics, and digital health platforms are increasing recognition of snoring as a medical concern rather than a mere inconvenience. Untreated snoring and OSA are linked to severe complications such as hypertension, stroke, heart disease, and cognitive decline. As patients become more informed, they are more likely to seek early intervention, creating strong demand for anti-snoring solutions that can be used at home without prescription.

Challenges in the Europe Anti-snoring Device Market

Limited Awareness in Certain Regions
While Western and Northern Europe have high awareness of sleep disorders, many regions in Eastern and Southern Europe continue to face underdiagnosis. Cultural stigma, limited access to sleep specialists, and insufficient public health education contribute to low adoption of anti-snoring therapy. The market remains concentrated in developed metropolitan areas, leaving large pockets of potential demand untapped.

Low Patient Compliance and Discomfort
Device adherence remains a major obstacle. Mandibular advancement devices and tongue-retaining devices are highly effective but often uncomfortable for long-term use, leading to jaw soreness, dry mouth, or sleep disturbance. Patients frequently discontinue use, reducing long-term effectiveness and lowering repeat purchases. Improving comfort and ergonomics remains critical for manufacturers aiming to enhance market penetration.

Regional Market Overview

United Kingdom
Growing awareness of sleep health, rising obesity rates, and wider acceptance of medically validated snoring treatments are boosting market adoption. UK consumers are increasingly turning to mandibular advancement devices, nasal dilators, and positional therapy tools. Strong e-commerce platforms, telehealth consultations, and an active wellness culture support market expansion. Demand is particularly strong among younger adults seeking non-invasive home solutions.

Germany
Germany has one of the strongest anti-snoring device markets in Europe due to its advanced healthcare infrastructure and high diagnostic rates of sleep disorders. Mandibular advancement devices are widely recommended, while smart wearables that monitor sleep and provide real-time snoring feedback are gaining popularity. Digital health expansion and a large base of sleep clinics support continued growth.

Italy
Italy's market growth is fueled by increasing public awareness and preference for non-invasive approaches to reduce snoring. Custom-fit oral appliances and advanced positional therapy devices are particularly popular. Although cost and comfort challenges exist, strong innovation and expanding online sales channels are supporting wider adoption.

France
France is experiencing strong demand for anti-snoring devices as consumers increasingly prioritize sleep wellness. Oral appliances remain the most common option, complemented by emerging smart devices that track sleep metrics. E-commerce has played a major role in expanding access to OTC products. Despite limitations related to cost and device comfort, ongoing innovation and rising sleep disorder awareness are expected to sustain market growth.

Market Segmentations

Product Categories

• Oral Appliances
• Nasal Devices
• Tongue-Stabilizing Devices
• Chin Straps
• Position Control Devices
• Expiratory Positive Airway Pressure (EPAP) Devices

Distribution Channels

• Retail Pharmacies
• Online Stores

End Users

• Homecare
• Others

Regional Coverage
France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Russia, Poland, Greece, Norway, Romania, Portugal, Rest of Europe

Company Coverage

Each company includes:
Overview • Key Persons • Recent Developments • Revenue Analysis

Key Players:
Koninklijke Philips N.V.
ResMed, Inc.
SomnoMed Limited
GSK Plc.
Apnea Sciences Corporation
ZQuiet (Sleeping Well, LLC)
Airway Management, Inc.
Fisher & Paykel Healthcare Limited
Tomed GmbH

If you